1. Home /
  2. Respiratory Health /
  3. Products /
  4. Otrivine /
  5. Product range /
  6. Otrivine product range

Otrivine products

Go To

Product range

A range of products to help relieve nasal congestion symptoms

A range of nasal decongestant products developed to relieve the symptoms of cold, allergy and sinusitis.

Call now to order

Pharmacy image

A range of products for professional recommendation.

Recommend Otrivine Nasal Sprays for symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hayfever), sinusitis.

Woman with tissue image

Otrivine Nasal Sprays provide relief from nasal congestion in as little as 2 minutes.

Recommend the Otrivine range to help patients to relieve nasal congestion symptoms

Otrivine Extra Dual Relief

Otrivine Extra Dual Relief 0.5 mg/ml + 0.6 mg/ml Nasal Spray

A new pharmacy-only medicine, available for you to supply and recommend in pharmacy, without a doctor’s prescription.

Otrivine Congestion Relief

Otrivine Congestion Relief 0.1% Nasal Spray

Provides relief in as little as 2 minutes, lasts up to 10 hours

Relieves symptoms of nasal congestion in connection with the common cold, perennial and allergic rhinitis (including hayfever) sinusitis. Combines the instant freshness of menthol with the decongestant power of Otrivine to help relieve even heavy forms of congestion

Suitable for use from 12 years and older

Do not use for more than 7 consecutive days.

Otrivine Adult Measured Dose Sinusitis

Otrivine Adult Measured Dose Sinusitis Spray

Provides relief in as little as 2 minutes, lasts up to 10 hours

Relieves symptoms of nasal congestion in connection with the common cold, perennial and allergic rhinitis (including hayfever) sinusitis.

Suitable for use from 12 years and older

Do not use for more than 7 consecutive days.

Otrivine Natural with eucalyptus

Otrivine Natural with Eucalyptus Nasal Spray

Contains sea water (hypertonic at 2.2% sea salt concentration), essential oil of Eucalyptus globulus, menthol extracted from Mentha arvensis. Natural relief from nasal congestion due to colds and rhinosinusitis

Suitable for use from 6 years and older

If symptoms persist beyond 7 days for adults and children, consult a healthcare professional

Otrivine Adult Spray 0.1% w/v

Otrivine Adult Spray 0.1% w/v

Provides relief in as little as 2 minutes, lasts up to 10 hours

Relieves symptoms of nasal congestion in connection with the common cold, perennial and allergic rhinitis (including hayfever) sinusitis.

Suitable for use from 12 years and older

Do not use for more than 7 consecutive days.

Otrivine Adult Drops

Otrivine Adult Nasal Drops

Relieves symptoms of nasal congestion in connection with the common cold, perennial and allergic rhinitis (including hayfever) sinusitis.

Suitable for use from 12 years and older

Do not use for more than 7 consecutive days.

Otrivine Child Nasal Drops

Otrivine Child Nasal Drops

Relieves symptoms of nasal congestion in connection with the common cold, perennial and allergic rhinitis (including hayfever) sinusitis. Lasts for up to 10 hours.

Suitable for use for 6 - 12 years

Do not use for more than 5 consecutive days.

Otrivine Range Product Information

  • Product information – Otrivine Extra Dual Relief

    Otrivine Extra Dual Relief 0.5 mg/ml + 0.6 mg/ml nasal spray, solution. (0.5 mg/ml xylometazoline hydrochloride and 0.6 mg/ml ipratropium bromide).

    Indications: Symptomatic treatment of nasal congestion and rhinorrhea in connection with common colds. 

    Dosage: 1 puff in each nostril, up to 3 times daily, with at least 6 hours between doses. Not for use longer than 7 days. 

    Contraindications: Children and adolescents under 18 years. Known hypersensitivity to xylometazoline hydrochloride or ipratropium bromide or any excipients or hypersensitivity to atropine or similar substances. Patients with glaucoma or rhinitis sicca or following trans-sphenoidal hypophysectomy or surgery exposing the dura mater. 

    Warnings and precautions: Use with caution in people with: hypertension, cardiovascular disease, hyperthyroidism, diabetes mellitus, prostatic hypertrophy, bladder stenosis, pheochromocytoma, angle closure glaucoma, epistaxis, paralytic ileus, cystic fibrosis. Caution in people sensitive to adrenergic substances, which may cause sleep disturbances, dizziness, tremor, cardiac arrythmias or elevated blood pressure. Hypersensitivity reactions may occur. Do not use for more than 7 days. Use during pregnancy or breastfeeding only if clearly necessary. Avoid contact with eyes. 

    Side effects:See SPC for full details. Hypersensitivity reactions (including angioedema, urticaria and bronchospasm). Localised irritation in the nose and throat, nausea, headache and dryness of the nasal mucosa. Systemic cardiovascular effects should be kept in mind in those with cardiovascular disease. In isolated cases, systemic allergic reactions, insomnia, fatigue, urine retention and transient visual disturbances.

    Price: £6.66 (ex. VAT)

    Legal Status: P. Licence Number: PL 44673/0153.

    Licence Holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, UK.

    Date of revision: April 2019

  • Product Information – Otrivine Congestion Relief

    Otrivine Congestion Relief 0.1% Nasal Spray. (1 mg/ml of xylometazoline hydrochloride and 0.14 mg of xylometazoline hydrochloride).

    Indications: For the symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hay fever) and sinusitis. 

    Dosage: Adults and adolescents over 12 years of age: 1 spray into each nostril, up to 3 times daily as needed. Do not exceed 3 applications daily into each nostril.

    Contraindications: Hypersensitivity to the active substance or to any of the excipients. Patients following trans-sphenoidal hypophysectomy or surgery exposing the dura mater. Patients with narrow-angle glaucoma, rhinitis sicca or atrophic rhinitis, phaeochromocytoma, prostatic hypertrophy, patients on MAOI treatment or who have received them in the last two weeks. Not to be used in children aged less than 12 years. 

    Warnings and precautions: Patients are advised not to take decongestants for more than seven consecutive days. Caution must be used in patients showing a strong reaction to adrenergic substances, which may cause signs of insomnia, dizziness, tremor, cardiac arrhythmias or elevated blood pressure. Caution is recommended in patients with hypertension, cardiovascular disease, hyperthyroidism or diabetes mellitus. Patients with long QT syndrome may be at increased of serious ventricular arrhythmias. This medicine contains polyoxyl hydrogenated castor oil which may cause skin reactions. If you are pregnant or taking other medicines or are under a doctor's care consult your doctor before using Otrivine.

    Side effects: See SPC for full details. Common: A burning sensation in the nose and throat, nausea, headache, nasal dryness and nasal discomfort. Very rare: Hypersensitivity reactions (including angioedema, rash, pruritus), transient visual impairment, irregular heart rate and increased heart rate.

    Price: £4.08 (ex. VAT)

    Legal Status: GSL.Licence Number: PL 44673/0151.

    Licence Holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, UK.

    Date of revision: December 2020.

  • Product Information – Otrivine Adult Measured Dose Sinusitis ; Adult Metered Dose ; Allergy Relief

    Otrivine Adult Measured Dose Sinusitis Spray / Otrivine Adult Metered Dose, 0.1% Nasal Spray / Otrivine Allergy Relief, 0.1% Nasal Spray. (0.1% w/v Xylometazoline Hydrochloride).

    Indications: For the symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hay fever) and sinusitis. 

    Dosage: Adults and elderly: One application in each nostril up to 3 times daily. Do not exceed 3 applications daily into each nostril. Not suitable for children under 12 years. 

    Contraindications: : Known hypersensitivity to xylometazoline. Patients following trans-sphenoidal hypophysectomy or surgery exposing the dura mater. Patients with narrow-angle glaucoma, rhinitis sicca or atrophic rhinitis, phaeochromocytoma, prostatic hypertrophy, patients on MAOI treatment or who have received them in the last two weeks. Not to be used in children aged less than 12 years. 

    Warnings and precautions: Patients are advised not to take decongestants for more than seven consecutive days. Caution must be used in patients showing a strong reaction to sympathomimetic agents which may cause signs of insomnia, dizziness, tremor, cardiac arrhythmias or elevated blood pressure. Caution is recommended in patients with hypertension, cardiovascular disease, hyperthyroidism or diabetes mellitus. Patients with long QT syndrome may be at increased of serious ventricular arrhythmias. Contains benzalkonium chloride, may cause irritation of the nasal mucosa. If you are pregnant or taking other medicines or are under a doctor's care, consult your doctor before using Otrivine.

    Side effects: Common: A burning sensation in the nose and throat, nausea, headache, nasal dryness and nasal discomfort. Very rare: transient visual impairment, irregular heart rate, increased heart rate and hypersensitivity reaction (including angioedema, rash, pruritus).

    Price: £3.49 (ex. VAT)

    Legal Status: GSL.

    Licence Number: PL 44673/0184.

    Licence Holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, UK.

    Date of revision: December 2020.

  • Product Information – Otrivine Adult Spray 0.1%

    Otrivine Adult Nasal Spray. (Xylometazoline Hydrochloride 0.1% w/v).

    Indications: For the treatment of nasal congestion, perennial and allergic rhinitis (including hay fever) and sinusitis.

    Dosage: Adults, children over 12 years and the elderly: One application in each nostril up to 3 times daily. Do not exceed 3 applications daily into each nostril. 

    Contraindications: Known hypersensitivity to Otrivine. Patients following trans-sphenoidal hypophysectomy or surgery exposing the dura mater. Patients with narrow-angle glaucoma, rhinitis sicca or atrophic rhinitis, phaeochromocytoma, prostatic hypertrophy, patients on MAOI treatment or who have received them in the last two weeks. Not to be used in children aged less than 12 years.  

    Warnings and precautions: Patients are advised not to take decongestants for more than seven consecutive days. Caution must be used in patients showing a strong reaction to sympathomimetic agents which may cause signs of insomnia, dizziness, tremor, cardiac arrhythmias or elevated blood pressure. Caution is recommended in patients with hypertension, cardiovascular disease, hyperthyroidism or diabetes mellitus. Patients with long QT syndrome may be at increased of serious ventricular arrhythmias. Contains benzalkonium chloride, may cause irritation of the nasal mucosa. If you are pregnant or taking other medicines or are under a doctor's care, consult your doctor before using Otrivine. 

    Side effects: Common: A burning sensation in the nose and throat, nausea, headache, nasal dryness or nasal discomfort. Very rare: transient visual impairment, irregular heart rate, increased heart rate, apnoea in young infants and hypersensitivity reaction (including angioedema, rash, pruritus). 

    Price: £2.91 (ex. VAT)

    Legal Status: GSL.

    Licence Number: PL 44673/0149.

    Licence Holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, UK.

    Date of revision: December 2020

  • Product Information – Otrivine Adult Nasal Drops

    Otrivine Adult Nasal Drops. (Xylometazoline Hydrochloride 0.1% w/v).

    Indications: For the symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hay fever) and sinusitis.

    Dosage: Adults and elderly (all indications): 2 or 3 drops in each nostril up to 3 times daily. Do not exceed 3 application daily into each nostril. The drops are suitable for children over 12 years of age.

    Contraindications: Known hypersensitivity to Otrivine. Patients following trans-sphenoidal hypophysectomy or surgery exposing the dura mater. Patients with narrow-angle glaucoma, rhinitis sicca or atrophic rhinitis, phaeochromocytoma, prostatic hypertrophy, patients on MAOI treatment or who have received them in the last two weeks. Not to be used in children aged less than 12 years.

    Warnings and precautions: Patients are advised not to take decongestants for more than seven consecutive days. Caution must be used in patients showing a strong reaction to sympathomimetic agents which may cause signs of insomnia, dizziness, tremor, cardiac arrhythmias or elevated blood pressure. Caution is recommended in patients with hypertension, cardiovascular disease, hyperthyroidism or diabetes mellitus. Patients with long QT syndrome may be at increased of serious ventricular arrhythmias. Contains benzalkonium chloride, may cause irritation of the nasal mucosa. If you are pregnant or taking other medicines or are under a doctor's care, consult your doctor before using Otrivine.

    Side effects: Common: A burning sensation in the nose and throat, nausea, headache, nasal dryness and nasal discomfort. Very rare: transient visual impairment, irregular heart rate, increased heart rate and hypersensitivity reaction(including angioedema, rash, pruritus).

    Price: £2.91 (ex. VAT)

    Legal Status: GSL.

    Licence Number: PL 44673/0148.

    Licence Holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, UK.

    Date of revision: December 2020

  • Product Information – Otrivine Child Nasal Drops

    Otrivine Child Nasal Drops. (Xylometazoline Hydrochloride 0.05% w/v).

    Indications: For the relief of nasal congestion associated with the common cold, perennial, allergic rhinitis (including hay fever) and sinusitis. 

    Dosage: Children between 6 and 12 years (all indications): 1 or 2 drops, in each nostril up to 2 times daily. Not to be used for more than 5 days without the advice of a doctor. Not more than 2 doses should be given in any 24 hours. Do not exceed the stated dose or take with any other cough and cold medicine.

    Contraindications: Known hypersensitivity to Otrivine or any of the excipients. Concomitant use of other sympathomimetic decongestants. Patients with cardiovascular disease including hypertension, diabetes mellitus, phaeochromocytoma, prostatic hypertrophy, hyperthyroidism, closed angle glaucoma or following transsphenoidal hypophysectomy or nasal surgery exposing the dura mater. Contraindicated in patients using monoamine oxidase inhibitors and beta-blockers or have inflammation of the skin and/or mucosa of the nasal vestibule. Not to be used in children under the age of 6 years.

    Warnings and precautions: Patients are advised not to take decongestants for more than five consecutive days. Caution must be used in patients showing a strong reaction to sympathomimetic agents which may cause signs of insomnia, dizziness, tremor, cardiac arrhythmias or elevated blood pressure. Caution in patients with occlusive vascular disease. Occasionally children may show restlessness, hallucinations or sleep disturbance when Otrivine is used. If this occurs Otrivine should be stopped. Contains benzalkonium chloride, may cause irritation of the nasal mucosa. Expectant mothers should consult their doctors before using Otrivine for themselves.

    Side effects: See SPC for full details. Common: Burning sensation in the nose and throat, nausea, headache, nasal dryness and nasal discomfort. Very rare: transient visual impairment, irregular heart rate, increased heart rate and hypersensitivity reaction (including angioedema, rash, pruritus). Unknown: Particularly with prolonged and/or excessive use Irritability, anxiety, cardiac dysrhythmias, hypertension, tolerance with diminished effect, rebound congestion, irritation.

    Price: £2.54 (ex. VAT)

    Legal Status: P.

    Licence Number: PL 44673/0147.

    Licence Holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, UK.

    Date of revision: December 2020.

Help your patients to manage their nasal congestion with Otrivine

Otrivine logo

Otrivine Extra Dual Relief

Find out how Otrivine Extra Dual Relief can help your customers and patients

FIND OUT MORE

Learning lab icon

Learning Lab

Access educational resources to build your knowledge and skills.

Access resources

Products icon

Orders

Contact us today to order products for your pharmacy

Order now